Compound derived from tropical wood protected motor neurons in ALS

The natural world has long been one of the most valuable resources in medicine: countless therapies originate from plants, fungi, or algae. Therefore, when researchers at the University of Wollongong (UOW) set out to find a new treatment for Amyotrophic Lateral Sclerosis (ALS), they turned to nature. Working in Professor Lezanne Ooi’s laboratory of neurodevelopment and neurodegeneration at Molecular Horizons at UOW, the researchers drew inspiration from the unique flora, fungi, and marine vertebrates of Australia and the Oceania region. They tested more than 500 different compounds on motor neurons — nerve cells that degenerate in ALS. The neurons were grown from stem cells obtained from people with sporadic ALS, which has no known genetic cause, and familial ALS, which is associated with inherited gene mutations.

Compound derived from tropical wood protected motor neurons in ALS

“For most cases of ALS, there are still no effective medications, and there is an urgent need to find new treatment methods for people living with ALS,” says the study’s author, Dr. Simon McShur. “The discovery of a compound derived from nature and showing promising results in protecting motor neurons in various forms of the disease is very encouraging.”

Two compounds stood out in the tests, both from the rainforest tree Anisoptera thurifera, which grows in Papua New Guinea, the Philippines, and Indonesia. A more effective compound, stilbenoid, protected motor neurons from degeneration and helped preserve their long, branching fibers, along which signals travel throughout the body. It also outperformed resvertral, a compound derived from grapes that has been widely studied for its protective effects.

Tested on motor neurons from 14 donors, both with sporadic ALS and with several genetic forms of the disease, stilbenoid protected the cells of 12 of them. He also reduced the hyperexcitable electrical activity characteristic of motor neurons in ALS, although only in some samples of sporadic ALS.

The compound works, in particular, by activating SIRT1 — a protein that helps cells cope with stress and damage. Since stilbenoid is predicted to pass poorly through the blood‑brain barrier and is difficult to produce, the researchers also tested SRT2104 — a low‑molecular‑weight drug that activates the same protein — to bring the finding closer to real results for patients.

“ALS varies greatly from person to person, and this is one of the main challenges in finding a treatment,” says experts from the UOW Laboratory of Neurodevelopment and Neurodegeneration. “Finding a compound extracted from nature that shows promising results in protecting motor neurons in various forms of the disease is very encouraging.”

McShur emphasized that the work is at an early stage but is based on groundbreaking research being conducted at UOW into the study, treatment, and prevention of this devastating neurodegenerative disease. The Anisoptera thurifera compounds were taken from a library assembled by Associate Professor Rohan Davis.

For scientists, these results serve as a reminder of the balance that exists between nature and medicine. “The natural world has given us many of our most important medicines, and this study suggests that it may have many more offerings in the fight against ALS and in opening up real prospects for drug development.”

Published

November, 2026

Category

Science

Duration of reading

2-3 min

Share

Global health science — in clear language

We select and translate the best international publications. Read 3 key materials about longevity every week!

Send us a message